Ventyx Biosciences Correlations

VTYX Stock

USD 1.32 0.01 0.75%

The current 90-days correlation between Ventyx Biosciences and Arcellx is 0.4 (i.e., Very weak diversification). The correlation of Ventyx Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Ventyx Biosciences Correlation With Market

Weak diversification

The correlation between Ventyx Biosciences and DJI is 0.32 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ventyx Biosciences and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Ventyx Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Ventyx Stock please use our How to Invest in Ventyx Biosciences guide.

Moving together with Ventyx Stock

0.81	CDIOW	Cardio Diagnostics	Pair Corr
0.87	VINC	Vincerx Pharma Earnings Call This Week	Pair Corr
0.65	ELEV	Elevation Oncology	Pair Corr
0.81	ELVN	Enliven Therapeutics	Pair Corr
0.83	GPCR	Structure Therapeutics	Pair Corr
0.92	ZURA	Zura Bio Limited	Pair Corr
0.86	IMMX	Immix Biopharma	Pair Corr
0.79	IMRX	Immuneering Corp	Pair Corr
0.91	MLTX	MoonLake Immunotherapeuti	Pair Corr
0.8	PMVP	Pmv Pharmaceuticals	Pair Corr
0.96	PYXS	Pyxis Oncology	Pair Corr
0.89	SCLX	Scilex Holding	Pair Corr
0.91	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.79	ATNF	180 Life Sciences	Pair Corr
0.71	AVTE	Aerovate Therapeutics	Pair Corr
0.64	SONN	Sonnet Biotherapeutics	Pair Corr
0.66	BIIB	Biogen Inc	Pair Corr

Moving against Ventyx Stock

0.92	AZN	AstraZeneca PLC ADR	Pair Corr
0.88	SNY	Sanofi ADR	Pair Corr
0.88	GILD	Gilead Sciences	Pair Corr
0.82	GOSS	Gossamer Bio	Pair Corr
0.73	OCX	OncoCyte Corp	Pair Corr
0.72	LLY	Eli Lilly	Pair Corr
0.57	PLX	Protalix Biotherapeutics	Pair Corr
0.49	BMY	Bristol Myers Squibb	Pair Corr
0.94	AMGN	Amgen Inc	Pair Corr
0.8	DRMAW	Dermata Therapeutics	Pair Corr
0.76	NVCT	Nuvectis Pharma	Pair Corr
0.57	CMPX	Compass Therapeutics	Pair Corr
0.35	RVP	Retractable Technologies Earnings Call This Week	Pair Corr

Related Correlations Analysis

	ACLX	IMCR	PCVX	DICE	NUVL	CERE	TVTX	GPCR	REPL
ACLX		-0.32	0.11	0.0	0.21	0.0	-0.69	0.39	-0.35	ACLX
IMCR	-0.32		0.41	0.0	0.34	0.0	0.3	0.33	0.46	IMCR
PCVX	0.11	0.41		0.0	0.84	0.0	0.04	0.84	0.4	PCVX
DICE	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	DICE
NUVL	0.21	0.34	0.84	0.0		0.0	0.15	0.77	0.57	NUVL
CERE	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	CERE
TVTX	-0.69	0.3	0.04	0.0	0.15	0.0		-0.29	0.66	TVTX
GPCR	0.39	0.33	0.84	0.0	0.77	0.0	-0.29		0.23	GPCR
REPL	-0.35	0.46	0.4	0.0	0.57	0.0	0.66	0.23		REPL
	ACLX	IMCR	PCVX	DICE	NUVL	CERE	TVTX	GPCR	REPL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

NUVL	+ 0.84	PCVX
GPCR	+ 0.84	PCVX
GPCR	+ 0.77	NUVL
REPL	+ 0.66	TVTX
REPL	+ 0.57	NUVL
REPL	+ 0.46	IMCR

High negative correlations

TVTX	- 0.69	ACLX
REPL	- 0.35	ACLX
IMCR	- 0.32	ACLX
GPCR	- 0.29	TVTX
REPL	- 0.0	CERE
GPCR	- 0.0	CERE

Risk-Adjusted Indicators

There is a big difference between Ventyx Stock performing well and Ventyx Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ventyx Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ACLX	2.33	(0.20)	0.00	(0.31)	0.00	0.00	4.79	(5.21)	10.80
IMCR	2.10	0.11	0.05	0.14	2.55	(2.12)	5.34	(4.18)	10.97
PCVX	2.23	(0.12)	0.00	(0.17)	0.00	0.00	3.86	(4.85)	19.90
DICE	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NUVL	2.06	(0.08)	0.00	(0.16)	0.00	0.00	3.54	(5.19)	12.24
CERE	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
TVTX	2.90	0.44	0.12	0.18	2.98	(3.62)	6.29	(4.94)	20.04
GPCR	3.70	(0.37)	0.00	(0.27)	0.00	0.00	6.92	(10.88)	25.66
REPL	2.83	(0.06)	0.00	(0.11)	0.00	0.00	5.86	(5.88)	22.75

Ventyx Biosciences Corporate Management

Matthew Moore	Chief Officer	Profile
Snehal Naik	Senior Development	Profile
Kye MD	Data Biostatistics	Profile
Sheila MD	Executive Chairperson	Profile
John Nuss	Chief Officer	Profile
Martin MD	Chief Officer	Profile
Kathy Ogilvie	Senior Research	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC